Claro Advisors Inc.: EFAV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Claro Advisors Inc. on EFAV, newest first. How the timeline and the estimate are built.
Claro Advisors Inc. held 2,965 EFAV shares at 2026-06-30 per its 13F-HR filed 2026-07-30.
the latest 13F is the newest step
- period ended2026-06-3013F 2,965 sharesChange vs previous 13F +21 shares
0.03% of the 13F portfolio, value $260,061.
13F-HR 0001951757-26-001082 filed by Claro Advisors Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 2,944 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $268,994.
13F-HR 0001951757-26-000657 filed by Claro Advisors Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 2,944 sharesChange vs previous 13F 0 shares
0.03% of the 13F portfolio, value $253,920.
13F-HR 0001951757-26-000472 filed by Claro Advisors Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 2,944 sharesChange vs previous 13F +180 shares
0.04% of the 13F portfolio, value $249,740.
13F-HR 0001951757-25-001396 filed by Claro Advisors Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,764 sharesChange vs previous 13F -25 shares
0.04% of the 13F portfolio, value $232,342.
13F-HR 0001951757-25-001033 filed by Claro Advisors Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 2,789 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $217,319.
13F-HR 0001951757-25-000537 filed by Claro Advisors Inc.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).